Figure 4.

Subgroup analysis for correlation between AKIP1 and EFS. A, Correlation between AKIP1 expression with EFS in better‐risk AML patients. B, Correlation between AKIP1 expression with EFS in intermediate‐risk AML patients. C, Correlation between AKIP1 expression with EFS in poor‐risk AML patients. K‐M curves were used to exhibit EFS. Comparison between groups was determined by log‐rank test. P value < .05 was considered significant. AKIP1, A‐kinase interacting protein 1; AML, acute myeloid leukemia; EFS, event‐free survival; K‐M curves, Kaplan‐Meier curves